Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ACA, atrophy, avoid, bioequivalence, Brasileiro, bridge, CDC, compound, counsel, counter, deposited, dolutegravir, Duavee, Eli, encouraging, entrant, essentially, exhausted, extraordinary, feedback, frequency, GEP, GIP, GlaxoSmithKline, hyperlipidemia, incontinence, incorrectly, infection, landscape, Lilly, lived, molecular, nonclinical, outpace, pivotal, polymorph, postmenopausal, proceed, prolonged, reassessing, recurrent, rejoined, restore, reward, screen, shutdown, stronger, timeframe, Tivicay, urge, urgency, urinary, usage, vulvar, withheld, Xanax
Removed:
antagonist, beta, blocker, Bristol, CHMP, confirmed, cord, diabetic, dialogue, disagree, educational, emphasizing, eye, Gestational, glaucoma, highlighting, hormone, Idiopathic, initiate, injection, Insufficiency, IX, met, muscarinic, negatively, nerve, neuralgia, neuropathy, occurring, ocular, packaging, PAH, proposition, prostaglandin, recombinant, Respimat, short, slightly, spinal, stature, streamline, sued, supported, Syndrome, Tennessee, thousand, timolol, Turner, voriconazole, warning, yeast
Filing tables
Filing exhibits
Related press release
PFE similar filings
Filing view
External links